Glucagon-like peptide-1 (GLP-1) is a neuroprotective substance which has been shown to protect neurons from amyloid toxicity in vitro as well as in vivo in Alzheimer's disease models [12,13]. The gene discussed is GLP1R; the disease is early-onset autosomal dominant Alzheimer disease.